Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS
Rosario Vasta, Fouke Ombelet, Frederik Hobin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALS
Robert McFarlane, Sarah Opie-Martin, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohort
Alejandro Caravaca Puchades, Harry E McDonough, Ammar Al-Chalabi, et al.
Nature Medicine
|
April 16, 2021
Altered perivascular fibroblast activity precedes ALS disease onset
Anna Månberg, Nathan Skene, Folkert Sanders, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALS
Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 21, 2025
Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonization
Emmet Costello, Joke De Vocht, Emily Beswick, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study
Ruben P A van Eijk, Daphne N Weemering, Sarah Opie-Martin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 31, 2023
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
Jeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Ebiomedicine
|
October 11, 2025
Optimised machine learning for time-to-event prediction in healthcare applied to timing of gastrostomy in ALS: a multi-centre, retrospective model development and validation study
Marcel Weinreich, Harry McDonough, Mark Heverin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
A yeast functional screen predicts new candidate ALS disease genes
Julien Couthouis, Michael P Hart, James Shorter, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS
Rosario Vasta, Fouke Ombelet, Frederik Hobin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALS
Robert McFarlane, Sarah Opie-Martin, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohort
Alejandro Caravaca Puchades, Harry E McDonough, Ammar Al-Chalabi, et al.
Nature Medicine
|
April 16, 2021
Altered perivascular fibroblast activity precedes ALS disease onset
Anna Månberg, Nathan Skene, Folkert Sanders, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALS
Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 21, 2025
Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonization
Emmet Costello, Joke De Vocht, Emily Beswick, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 6, 2025
Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study
Ruben P A van Eijk, Daphne N Weemering, Sarah Opie-Martin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 31, 2023
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
Jeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Ebiomedicine
|
October 11, 2025
Optimised machine learning for time-to-event prediction in healthcare applied to timing of gastrostomy in ALS: a multi-centre, retrospective model development and validation study
Marcel Weinreich, Harry McDonough, Mark Heverin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
A yeast functional screen predicts new candidate ALS disease genes
Julien Couthouis, Michael P Hart, James Shorter, et al.
Page
of 9